Development and Application of Physiologically-Based Pharmacokinetic Model to Predict Systemic and Organ Exposure of Colorectal Cancer Drugs
Background/Objectives: Colorectal cancer (CRC) holds the third and second position among cancers affecting men and women, respectively. Frequently, the first-line treatment for metastatic CRC consists of the intravenous administration of 5-fluorouracil and leucovorin in combination with oxaliplatin...
Saved in:
Main Authors: | Sara Peribañez-Dominguez, Zinnia Parra-Guillen, Iñaki F. Troconiz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/17/1/57 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A physiologically-based pharmacokinetic model for the antibiotic ertapenem
by: Michele L. Joyner, et al.
Published: (2015-09-01) -
Physiologically Based Pharmacokinetic Modeling of Cannabidiol, Delta‐9‐Tetrahydrocannabinol, and Their Metabolites in Healthy Adults After Administration by Multiple Routes
by: Lixuan Qian, et al.
Published: (2025-01-01) -
Improving Individualized Salbutamol Treatment: A Population Pharmacokinetic Model for Oral Salbutamol in Virtual Patients
by: Lara Marques, et al.
Published: (2024-12-01) -
Whole-Body Physiologically Based Pharmacokinetic Modeling of GalNAc-Conjugated siRNAs
by: Emilie Langeskov Salim, et al.
Published: (2025-01-01) -
Physiologically-based pharmacokinetic modeling of enantioselective hydroxychloroquine kinetics and impact of genetic polymorphisms
by: Gabriella de Souza Gomes Ribeiro, et al.
Published: (2025-01-01)